Log in

NASDAQ:TYMETyme Technologies Stock Price, Forecast & News

$1.51
+0.05 (+3.42 %)
(As of 06/5/2020 04:00 PM ET)
Add
Compare
Today's Range
$1.47
Now: $1.51
$1.55
50-Day Range
$1.10
MA: $1.40
$1.70
52-Week Range
$0.86
Now: $1.51
$2.04
Volume400,636 shs
Average Volume352,291 shs
Market Capitalization$185.49 million
P/E RatioN/A
Dividend YieldN/A
Beta0.97
Tyme Technologies, Inc., a clinical-stage biotechnology company, develops novel cancer therapeutics. It is developing SM-88, a combination therapy based on dysfunctional metyrosine derivatives in Phase II development for metastatic pancreatic cancer and biomarker-recurrent prostate cancer. The company was founded in 2011 and is headquartered in New York, New York.
Read More
Tyme Technologies logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.31 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:TYME
CUSIPN/A
Phone212-461-2315

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$0.15 per share

Profitability

Net Income$-22,000,000.00

Miscellaneous

Employees11
Market Cap$185.49 million
Next Earnings Date8/13/2020 (Estimated)
OptionableOptionable

Receive TYME News and Ratings via Email

Sign-up to receive the latest news and ratings for TYME and its competitors with MarketBeat's FREE daily newsletter.

Tyme Technologies (NASDAQ:TYME) Frequently Asked Questions

How has Tyme Technologies' stock been impacted by COVID-19 (Coronavirus)?

Tyme Technologies' stock was trading at $1.05 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, TYME shares have increased by 43.8% and is now trading at $1.51. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Tyme Technologies?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tyme Technologies in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Tyme Technologies.

When is Tyme Technologies' next earnings date?

Tyme Technologies is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for Tyme Technologies.

How were Tyme Technologies' earnings last quarter?

Tyme Technologies Inc (NASDAQ:TYME) released its quarterly earnings results on Wednesday, May, 20th. The company reported ($0.04) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.07) by $0.03. View Tyme Technologies' earnings history.

What price target have analysts set for TYME?

1 brokers have issued 1 year target prices for Tyme Technologies' stock. Their forecasts range from $9.50 to $9.50. On average, they expect Tyme Technologies' share price to reach $9.50 in the next twelve months. This suggests a possible upside of 529.1% from the stock's current price. View analysts' price targets for Tyme Technologies.

Has Tyme Technologies been receiving favorable news coverage?

News coverage about TYME stock has trended positive recently, according to InfoTrie Sentiment Analysis. The research firm ranks the sentiment of press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Tyme Technologies earned a coverage optimism score of 3.0 on InfoTrie's scale. They also gave news stories about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the near term. View the latest news aboutTyme Technologies.

Are investors shorting Tyme Technologies?

Tyme Technologies saw a decline in short interest in May. As of May 15th, there was short interest totaling 4,740,000 shares, a decline of 7.1% from the April 30th total of 5,100,000 shares. Based on an average daily volume of 382,400 shares, the short-interest ratio is currently 12.4 days. Currently, 8.8% of the company's shares are short sold. View Tyme Technologies' Current Options Chain.

Who are some of Tyme Technologies' key competitors?

What other stocks do shareholders of Tyme Technologies own?

Who are Tyme Technologies' key executives?

Tyme Technologies' management team includes the following people:
  • Mr. Steven E. Hoffman, Co-Founder, Chairman, CEO & Chief Science Officer (Age 56)
  • Mr. Ben R. Taylor, Pres & CFO (Age 42)
  • Mr. Michael S. Demurjian, Co-Founder, Exec. VP, COO & Director (Age 52)
  • Mr. James Biehl J.D., Chief Legal Officer & Sec. (Age 55)
  • Dr. Giuseppe Del Priore, Chief Medical Officer (Age 57)

What is Tyme Technologies' stock symbol?

Tyme Technologies trades on the NASDAQ under the ticker symbol "TYME."

Who are Tyme Technologies' major shareholders?

Tyme Technologies' stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (3.27%), State Street Corp (1.15%), Geode Capital Management LLC (0.64%), Nuveen Asset Management LLC (0.20%), Morgan Stanley (0.12%) and Perkins Capital Management Inc. (0.10%). Company insiders that own Tyme Technologies stock include Barbara Galaini, David Carberry, Douglas A Michels, Michael Demurjian, Michele Ilene Korfin and Steve Hoffman. View institutional ownership trends for Tyme Technologies.

Which institutional investors are selling Tyme Technologies stock?

TYME stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Morgan Stanley, Wells Fargo & Company MN, Perkins Capital Management Inc., and UBS Group AG. View insider buying and selling activity for Tyme Technologies.

Which institutional investors are buying Tyme Technologies stock?

TYME stock was purchased by a variety of institutional investors in the last quarter, including Spark Investment Management LLC, Geode Capital Management LLC, Nuveen Asset Management LLC, State Street Corp, and Advisor Group Holdings Inc.. Company insiders that have bought Tyme Technologies stock in the last two years include Barbara Galaini, David Carberry, Douglas A Michels, Michele Ilene Korfin, and Steve Hoffman. View insider buying and selling activity for Tyme Technologies.

How do I buy shares of Tyme Technologies?

Shares of TYME can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Tyme Technologies' stock price today?

One share of TYME stock can currently be purchased for approximately $1.51.

How big of a company is Tyme Technologies?

Tyme Technologies has a market capitalization of $185.49 million. The company earns $-22,000,000.00 in net income (profit) each year or ($0.17) on an earnings per share basis. Tyme Technologies employs 11 workers across the globe.

What is Tyme Technologies' official website?

The official website for Tyme Technologies is www.tymeinc.com.

How can I contact Tyme Technologies?

Tyme Technologies' mailing address is 17 STATE STREET 7TH FLOOR, NEW YORK NY, 10004. The company can be reached via phone at 212-461-2315 or via email at [email protected]

This page was last updated on 6/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.